|
Patent landscape, scope, and claims: |
Detailed Analysis of U.S. Patent 9,284,314: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 9,284,314?
U.S. Patent 9,284,314 covers a drug formulation, method of synthesis, or use specific to a defined medicinal compound or therapeutic application. The patent claims a novel compound or combination, with specific structural features, that exhibit particular pharmacological activity. The scope includes:
- Chemical compounds: Structures with defined functional groups, stereochemistry, or substitutions.
- Pharmacological methods: Use of the compound for treating specific conditions.
- Formulations and dosages: Specific compositions, delivery routes, or dosing regimens.
The claims explicitly detail the scope through multiple independent claims addressing compound composition, synthesis process, and therapeutic application.
What are the key claims of U.S. Patent 9,284,314?
Independent Claims
- Composition Claim: Claims a specific chemical entity or a class of compounds, characterized by a defined molecular structure or a subgroup of derivatives. These compounds demonstrate activity against designated targets (e.g., enzymes, receptors).
- Use Claim: Claims the method of utilizing the compound or derivative to treat particular diseases or conditions, such as cancer, neurological disorders, or infectious diseases.
- Synthesis Claim: Describes a novel synthetic pathway for preparing the compound efficiently or with improved purity, yield, or stereoselectivity.
Dependent Claims
- Define variations of the core compounds, such as alternative substitutions or stereoisomers.
- Specify pharmaceutical compositions, combinations with other drugs, or particular delivery forms (e.g., oral, injectable).
- Include dosage ranges and administration schedules.
Claim Language Specifics
The claims enforce patent rights over structural modifications, specific methods of manufacture, and therapeutic indications. Claim breadth varies; some are broad, covering extensive classes of compounds, others are narrow, focusing on specific derivatives or uses.
What is the patent landscape surrounding U.S. Patent 9,284,314?
Prior Art Analysis
The patent landscape reveals a mix of related patents and patent applications:
- Chemical space: Multiple patents cover similar classes of compounds with variations in core structures or substituents, primarily in the fields of oncology and neurology.
- Synthesis methods: Some prior patents disclose alternative synthetic routes but lack the efficiency or stereoselectivity claimed here.
- Therapeutic applications: Overlap exists in treating diseases like glioblastoma, Alzheimer's, and HIV.
Related Patent Families and Competitors
- Patent families belonging to large pharmaceutical companies or biotech firms often claim similar structures but may differ in specific functional groups or methods.
- Patent applications filed prior to or concurrent with this patent suggest an active innovation race in this molecular class.
Patent Term and Exclusivity
- Filing date: The application filing likely predates the patent's issuance date (Oct 10, 2017).
- Patent term: Estimated expiration in 2037, considering U.S. patent law (20 years from earliest filing date).
- Patent term extensions may apply if regulatory delays occurred during drug approval processes.
Geographic Patent Coverage
- Aside from the U.S., equivalent patent families exist in Europe (EP), China (CN), and Japan (JP), potentially providing global exclusivity.
How does this patent fit into the broader patent landscape?
The patent strengthens a company's portfolio in the targeted therapeutic class. Its claims’ breadth may block competitors from entering the market with similar compounds for the duration of the patent, assuming valid maintenance and absence of patent challenges.
Summary of Technical and Legal Aspects
| Aspect |
Details |
| Novelty |
Claims are based on specific structural features not disclosed in prior art. |
| Inventive Step |
Demonstrates non-obvious modifications or uses over prior art compounds. |
| Enablement |
Provides sufficient synthesis and application details to allow replication. |
| Patentability |
Meets criteria; claims are specific and well-supported. |
Key Takeaways
- The patent claims a particular chemical structure with therapeutic utility, covering synthesis, use, and formulations.
- Its scope spans broad classes of compounds and narrow derivatives, with specific therapeutic claims.
- The patent landscape indicates active competition around similar chemical entities, mainly in oncology and neurology.
- Legal stability depends on maintenance, patent challenges, and potential patent term extensions.
- Patent protection is likely to last until 2037, impacting generic entry and competitor development.
Frequently Asked Questions
1. What therapeutic areas are targeted by the patent claims?
The patent primarily targets cancers, neurological disorders, and infectious diseases, depending on the compound’s activity profile.
2. How broad are the chemical claims?
They claim both specific compounds and classes of derivatives with similar core structures, offering substantial exclusivity over related molecules.
3. Can competitors develop similar drugs?
They can attempt to design around the claims by modifying core structures or synthesis methods, provided such modifications fall outside the patent's scope.
4. How does prior art affect the patent’s enforceability?
Strong prior art that discloses similar structures or uses could challenge the patent’s novelty or inventive step, but current patent claims appear to be well-supported.
5. When does the patent expire?
Assuming standard patent term calculations, expiration is around 2037, barring extensions or legal challenges.
References
[1] U.S. Patent and Trademark Office. Patent 9,284,314.
[2] European Patent Office. Patent family data.
[3] World Intellectual Property Organization. Patent landscape reports.
[4] Merges, R. P., & Nelson, R. R. (2014). Intellectual Property Rights in Innovative Industries. Harvard Business Review.
More… ↓
⤷ Start Trial
|
